Tri-Heal Dosage Protocol | PeptideDosages.com

Tri-Heal (45 mg Blend) Dosage Protocol

Tri-Heal Dosage Chart

The Tri-Heal peptide blend is dosed at 500 mcg–2 mg daily via subcutaneous injection in educational protocols. A 45 mg blend reconstituted with bacteriostatic water yields about 15 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → 15 mg/mL concentration (15,000 mcg/mL).

Typical daily range: 500–2000 mcg once daily (gradual titration over 8 weeks).

Easy measuring: At 15 mg/mL, 1 unit = 0.01 mL = 150 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles[5].

Tri-Heal is a research peptide blend combining TB-500 (25 mg), BPC-157 (10 mg), and KPV (10 mg) for advanced tissue repair and inflammation modulation[1]. TB-500 is a synthetic fragment of thymosin β4, a 43-amino-acid peptide involved in cell migration, angiogenesis, and wound healing[2]. BPC-157 is a synthetic 15-amino-acid body protection compound with pro-angiogenic and gastroprotective properties[3]. KPV (Lys-Pro-Val) is a tripeptide derived from α-MSH noted for potent anti-inflammatory effects[4]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Related research: For distinct compound, component, or formulation evidence and safety context, read BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research, TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research, and KPV Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

Standard 8-Week Protocol (3 mL = 15 mg/mL)

Weeks 1–2

500 mcg

0.5 mg

3.3 units*

0.033 mL

Weeks 3–4

1000 mcg

1.0 mg

6.7 units*

0.067 mL

Weeks 5–6

1500 mcg

1.5 mg

10 units

0.10 mL

Weeks 7–8

2000 mcg

2.0 mg

13.3 units

0.133 mL

*Precision Note: For doses ≤10 units (≤0.10 mL), consider using 30-unit or 50-unit insulin syringes for improved readability and accuracy.

Frequency: Inject once daily subcutaneously[6]. This schedule uses the largest practical dilution (3.0 mL) to optimize syringe accuracy across all dose levels.

Extended 12-Week Protocol (3 mL = 15 mg/mL)

Weeks 9–10

2500 mcg

2.5 mg

16.7 units

0.167 mL

Weeks 11–12

3000 mcg

3.0 mg

20 units

0.20 mL

Extended 16-Week Protocol (3 mL = 15 mg/mL)

Weeks 13–14

3500 mcg

3.5 mg

23.3 units

0.233 mL

Weeks 15–16

4000 mcg

4.0 mg

26.7 units

0.267 mL

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming or direct stream onto the lyophilized cake.

Gently swirl or roll until fully dissolved (do not shake vigorously).

Label with date and concentration (15 mg/mL); refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

8 weeks (56 doses, ~70 mg total): 2 vials

12 weeks (84 doses, ~147 mg total): 4 vials

16 weeks (112 doses, ~252 mg total): 6 vials

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Recommendation: Include 30-unit or 50-unit syringes for the early low-dose phases (Weeks 1–4) where precision is critical.

8 weeks (2 vials): 6 mL → 1 × 10 mL bottle

12 weeks (4 vials): 12 mL → 2 × 10 mL bottles

16 weeks (6 vials): 18 mL → 2 × 10 mL bottles

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support tissue repair, regeneration, and inflammation modulation through synergistic peptide action[2][3][4].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).

Dose Range: 500–4000 mcg daily with gradual titration.

Reconstitution: 3.0 mL per 45 mg vial (15 mg/mL) for accurate unit measurements.

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw[5].

Dosing Protocol

Suggested daily titration approach.

Start: 500 mcg daily; increase by 500 mcg every 2 weeks as tolerated.

Target: 1500–2000 mcg daily by Weeks 5–8 (standard); up to 3000–4000 mcg for extended protocols.

Frequency: Once per day (subcutaneous).

Cycle Length: 8–12 weeks; optional extension to 16 weeks.

Timing: Any consistent time; rotate injection sites systematically.

Storage Instructions

Proper storage preserves peptide quality and potency.

Lyophilized: Store at −20 °C (−4 °F) or colder (ideally −80 °C / −112 °F for long-term) in dry, dark conditions[5].

Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks; prepare aliquots if needed and avoid freeze–thaw cycles[5].

Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container.

Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy[6].

Inject slowly; wait a few seconds before withdrawing the needle.

Document daily dose, site rotation, and any observations to maintain consistency.

For doses under 10 units, use 30-unit or 50-unit insulin syringes for improved accuracy.

How This Works

Tri-Heal combines three peptides with complementary mechanisms targeting multiple aspects of tissue injury repair:

TB-500 (Thymosin β4): Acts as a natural repair factor, inhibiting inflammation and apoptosis while promoting angiogenesis, cell migration, and matrix remodeling[2][7]. This 43-amino-acid peptide has been shown to accelerate dermal healing in both preclinical models and clinical applications[2].

BPC-157 (Body Protection Compound): Enhances healing via VEGFR2/Akt-eNOS activation, increasing nitric oxide production and angiogenesis while stimulating fibroblast activity[8]. This 15-amino-acid gastric peptide accelerates tendon, muscle, and gut repair[3][9].

KPV (Lys-Pro-Val): Provides anti-inflammatory effects by reducing NF-κB activation and attenuating pro-inflammatory cytokine signaling in epithelial and immune cells[4]. This α-MSH-derived tripeptide complements the regenerative actions of TB-500 and BPC-157.

The combination thus addresses wound repair, angiogenesis, and inflammation simultaneously through distinct but synergistic pathways.

Potential Benefits & Side Effects

Observations from preclinical and clinical literature on the individual components.

TB-500: Promotes cell proliferation, angiogenesis, and accelerated tissue repair; inhibits apoptosis and inflammation in healing tissues[2][7].

BPC-157: Accelerates musculoskeletal healing including tendon and muscle repair; stimulates endothelial regeneration and fibroblast activity[3][9].

KPV: Reduces inflammatory cytokine release; demonstrates efficacy in models of epithelial inflammation[4].

General tolerability: Individual peptides are generally well tolerated in preclinical studies; occasional mild injection-site reactions (redness, transient discomfort) may occur with subcutaneous administration.

Note: Human clinical data on this specific combination is limited; observations are extrapolated from studies of individual components.

Lifestyle Factors

Complementary strategies for optimal recovery outcomes.

Pair with adequate protein intake (1.6–2.2 g/kg body weight) to support tissue regeneration.

Maintain appropriate activity levels; avoid overloading healing tissues while promoting controlled movement.

Prioritize sleep (7–9 hours) to maximize endogenous repair processes.

Manage stress through appropriate techniques, as chronic stress impairs healing.

Stay well-hydrated and maintain balanced micronutrient intake (vitamin C, zinc, collagen precursors).

Injection Technique

General subcutaneous guidance from clinical best-practice resources[6].

Clean the vial stopper and skin with alcohol; allow to dry completely before proceeding.

Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[6][10].

Do not aspirate for subcutaneous injections; inject slowly and steadily[6].

Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy and local irritation[11].

Dispose of used syringes in an approved sharps container; never recap or reuse needles.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. For research use only. Not for human consumption.

References

Pure Lab Peptides — Tri-Heal (45 mg) product page; blend composition and specifications View Source

Annals of the New York Academy of Sciences (2012) — The regenerative peptide thymosin β4 accelerates dermal healing in preclinical models and patients View Source

HSS Journal / PMC (2025) — Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review View Source

Molecular Therapy Methods & Clinical Development / PMC (2017) — Orally Targeted Delivery of Tripeptide KPV via HA-Functionalized Nanoparticles Alleviates Ulcerative Colitis View Source

Clinical Chemistry (2016) — Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays View Source

CDC Pink Book (2024) — Vaccine Administration: subcutaneous route technique, angle, and site guidance View Source

Frontiers in Endocrinology (2021) — Progress on the Function and Application of Thymosin β4 View Source

Current Reviews in Musculoskeletal Medicine (2025) — Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing View Source

Journal of Orthopaedic Research (2003) — Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and stimulates tendocyte growth View Source

CDC (Subcutaneous Injection PDF) — Technique diagram and site guidance for subcutaneous injections View Source

NCBI Bookshelf — Best practices for injection: asepsis, preparation, and administration View Source

Additional Research and Background

These sources provide related context and are not presented as support for a specific statement above.

Subcutaneous Drug Injection Review / PMC — Pharmacologic considerations of the subcutaneous route View Source

Related research, protocols, and guides

Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.

Research overview

BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research

TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research

KPV Peptide: Benefits, Uses, Side Effects, Dosage, and Research

Related protocols and comparisons

BPC-157 (5 mg Vial) Dosage Protocol

BPC-157 (10 mg Vial) Dosage Protocol

BPC-157 + TB-500 (10 mg Blend) Dosage Protocol

BPC-157 + TB-500 (20 mg Blend) Dosage Protocol

TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol

GLOW (70 mg Blend) Dosage Protocol

KLOW (80 mg Blend) Dosage Protocol

TB-500 (5 mg Vial) Dosage Protocol

Practical guides

Peptide Blend Dosages

Peptide Dosage & Reconstitution Calculator

How to Reconstitute Peptides

Syringe & Measurement Guide

Peptide Storage Guide

Peptide Dosage Chart